Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Procrit, Camptosar At Risk Under 2005 Medicare Payment Rates, ASCO Says

Executive Summary

Medicare reimbursement rates for 2005 will not cover costs of Johnson & Johnson's Procrit (epoetin) for the majority of oncology practices, according to the American Society of Clinical Oncology

You may also be interested in...



Medicare Cancer Drug Administration Code Changes Follow AMA Proposal

The Centers for Medicare & Medicaid Services will implement new codes for oncology care based on American Medical Association recommendations

Medicare Cancer Drug Administration Code Changes Follow AMA Proposal

The Centers for Medicare & Medicaid Services will implement new codes for oncology care based on American Medical Association recommendations

Average Sales Prices Expected To Increase 3.4% From Proposed Rule

The Centers for Medicare & Medicaid Services expects that first quarter 2005 reimbursement rates for Medicare Part B drugs will reflect an increase of about 3.4% from those published in its proposed rule

Related Content

Topics

UsernamePublicRestriction

Register

PS044652

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel